(Q46211863)

20 December 2017

title

Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease (English)

1 reference

20 December 2017

0 references

Marcus A Mall

1

1 reference

20 December 2017

publication date

5 December 2008

1 reference

20 December 2017

published in

Experimental Physiology

1 reference

20 December 2017

volume

94

1 reference

20 December 2017

page(s)

171-174

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

21 January 2018

Proteases and emphysema

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis L

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Modelling dysregulated Na+ absorption in airway epithelial cells with mucosal nystatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Wild type but not deltaF508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

CFTR as a cAMP-dependent regulator of sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Death by necrosis. Uncontrollable catastrophe, or is there order behind the chaos?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Viral induction of a chronic asthma phenotype and genetic segregation from the acute response

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2008.042994

10.1113/EXPPHYSIOL.2008.042994

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19060118

1 reference

20 December 2017